Caricamento...
13.1 ENDOCANNABINOID MODULATION OF DOPAMINE NEUROTRANSMISSION
BACKGROUND: Dopamine is the major neurotransmitter implicated in schizophrenia pathology. Thus, understanding the processes modulating dopaminergic signalling may lead to new insights in the biology and treatment of this disorder. The endocannabinoids anandamide and 2-arachidonoylglicerol (2-AG) mod...
Salvato in:
| Pubblicato in: | Schizophr Bull |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5888798/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby014.049 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|